These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 16868535)
1. New radiopharmaceuticals for imaging rheumatoid arthritis. Chianelli M; D'Alessandria C; Conti F; Priori R; Valesini G; Annovazzi A; Signore A Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):217-25. PubMed ID: 16868535 [TBL] [Abstract][Full Text] [Related]
2. The developing role of peptide radiopharmaceuticals in the study of chronic inflammation: new techniques for novel therapeutic options. Chianelli M; Parisella MG; D'Alessandria C; Corsetti F; Scopinaro F; Signore A Q J Nucl Med; 2003 Dec; 47(4):256-69. PubMed ID: 14973418 [TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies. Malviya G; Conti F; Chianelli M; Scopinaro F; Dierckx RA; Signore A Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):386-98. PubMed ID: 19777175 [TBL] [Abstract][Full Text] [Related]
4. Advances in positron emission tomography for the imaging of rheumatoid arthritis. Narayan N; Owen DR; Taylor PC Rheumatology (Oxford); 2017 Nov; 56(11):1837-1846. PubMed ID: 28181650 [TBL] [Abstract][Full Text] [Related]
5. Combination of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging is an optimal way to evaluate rheumatoid arthritisin rats dynamically. Zhang WT; DU XK; Huo TL; Wei ZM; Hao CX; An B Chin Med J (Engl); 2013; 126(19):3732-8. PubMed ID: 24112173 [TBL] [Abstract][Full Text] [Related]
6. The clinical role of nuclear medicine in rheumatoid arthritis patients. A comparison with other diagnostic imaging modalities. Vos K; Van der Linden E; Pauwels EK Q J Nucl Med; 1999 Mar; 43(1):38-45. PubMed ID: 10230280 [TBL] [Abstract][Full Text] [Related]
7. Single-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disorders. Seibyl JP Semin Nucl Med; 2008 Jul; 38(4):274-86. PubMed ID: 18514083 [TBL] [Abstract][Full Text] [Related]
8. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Goerres GW; Forster A; Uebelhart D; Seifert B; Treyer V; Michel B; von Schulthess GK; Kaim AH Clin Nucl Med; 2006 Jul; 31(7):386-90. PubMed ID: 16785804 [TBL] [Abstract][Full Text] [Related]
9. Neuronuclear assessment of patients with epilepsy. Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079 [TBL] [Abstract][Full Text] [Related]
10. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Paulos CM; Turk MJ; Breur GJ; Low PS Adv Drug Deliv Rev; 2004 Apr; 56(8):1205-17. PubMed ID: 15094216 [TBL] [Abstract][Full Text] [Related]
11. The role of magnetic resonance imaging in the early diagnosis of rheumatoid arthritis. Ashikyan O; Tehranzadeh J Top Magn Reson Imaging; 2007 Jun; 18(3):169-76. PubMed ID: 17762381 [TBL] [Abstract][Full Text] [Related]
12. New agents for scintigraphy in rheumatoid arthritis. de Bois MH; Pauwels EK; Breedveld FC Eur J Nucl Med; 1995 Nov; 22(11):1339-46. PubMed ID: 8575488 [TBL] [Abstract][Full Text] [Related]
13. Kinetic modeling of contrast-enhanced MRI: an automated technique for assessing inflammation in the rheumatoid arthritis wrist. Zierhut ML; Gardner JC; Spilker ME; Sharp JT; Vicini P Ann Biomed Eng; 2007 May; 35(5):781-95. PubMed ID: 17340197 [TBL] [Abstract][Full Text] [Related]
14. Nuclear imaging of autoimmunity: focus on IBD and RA. McBride HJ Autoimmunity; 2010 Nov; 43(7):539-49. PubMed ID: 20388060 [TBL] [Abstract][Full Text] [Related]
15. Treatment of rheumatoid arthritis: Unraveling the conundrum. Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757 [TBL] [Abstract][Full Text] [Related]